APO Research
Talk to an analyst

APO RESEARCH · REPORT

GMP Plasmid Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GMP Plasmid Service Market Analysis and Forecast 2026-2032

28 December 2025196 pages

Choose your research edition.

Industry ResearchGMP Plasmid Service Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal GMP Plasmid Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal GMP Plasmid Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GMP Plasmid Service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal GMP Plasmid Service Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global GMP Plasmid Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for GMP Plasmid Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GMP Plasmid Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GMP Plasmid Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GMP Plasmid Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of GMP Plasmid Service include Aldevron, Andelyn Biosciences, Anemocyte, Catalent Biologics, Creative Biolabs, Esco Aster, VectorBuilder, Eurogentec and Pharmaron, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for GMP Plasmid Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GMP Plasmid Service, also provides the revenue of main regions and countries. Of the upcoming market potential for GMP Plasmid Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GMP Plasmid Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GMP Plasmid Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for GMP Plasmid Service revenue, projected growth trends, production technology, application and end-user industry.

GMP Plasmid Service Segment by Company

Aldevron

Andelyn Biosciences

Anemocyte

Catalent Biologics

Creative Biolabs

Esco Aster

VectorBuilder

Eurogentec

Pharmaron

PlasmidFactory GmbH

ProBio CDMO

Sartorius

Takara Bio

GMP Plasmid Service Segment by Type

Plasmid for Viral Vector Production

Plasmid for Direct-Acting Therapeutics

Plasmid for In Vitro Transcription Template

Others

GMP Plasmid Service Segment by Application

Gene Therapy and Cell Therapy Industry

mRNA Vaccine and Therapy Industry

Diagnostic and Scientific Research Reagent Industry

Others

GMP Plasmid Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Plasmid Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GMP Plasmid Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Plasmid Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of GMP Plasmid Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of GMP Plasmid Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP Plasmid Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GMP Plasmid Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plasmid for Viral Vector Production Major Player Table 3. Plasmid for Direct-Acting Therapeutics Major Player Table 4. Plasmid for In Vitro Transcription Template Major Player Table 5. Others Major Player Table 6. Global GMP Plasmid Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Gene Therapy and Cell Therapy Industry Major Player Table 8. mRNA Vaccine and Therapy Industry Major Player Table 9. Diagnostic and Scientific Research Reagent Industry Major Player Table 10. Others Major Player Table 11. GMP Plasmid Service Industry Trends Table 12. GMP Plasmid Service Industry Drivers Table 13. GMP Plasmid Service Industry Opportunities and Challenges Table 14. GMP Plasmid Service Industry Restraints Table 15. Global GMP Plasmid Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global GMP Plasmid Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global GMP Plasmid Service Market Share by Region (2021-2026) Table 18. Global GMP Plasmid Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global GMP Plasmid Service Market Share by Region (2027-2032) Table 20. Global GMP Plasmid Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global GMP Plasmid Service Revenue Market Share by Players (2021-2026) Table 22. Global GMP Plasmid Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global GMP Plasmid Service Key Players Headquarters & Area Served Table 24. Global GMP Plasmid Service Players, Product Type & Application Table 25. Global GMP Plasmid Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global GMP Plasmid Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global GMP Plasmid Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global GMP Plasmid Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global GMP Plasmid Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global GMP Plasmid Service Revenue Market Share by Type (2021-2026) Table 32. Global GMP Plasmid Service Revenue Market Share by Type (2027-2032) Table 33. Global GMP Plasmid Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global GMP Plasmid Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global GMP Plasmid Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global GMP Plasmid Service Revenue Market Share by Application (2021-2026) Table 37. Global GMP Plasmid Service Revenue Market Share by Application (2027-2032) Table 38. Aldevron Company Information Table 39. Aldevron Business Overview Table 40. Aldevron GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Aldevron GMP Plasmid Service Product Portfolio Table 42. Aldevron Recent Development Table 43. Andelyn Biosciences Company Information Table 44. Andelyn Biosciences Business Overview Table 45. Andelyn Biosciences GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Andelyn Biosciences GMP Plasmid Service Product Portfolio Table 47. Andelyn Biosciences Recent Development Table 48. Anemocyte Company Information Table 49. Anemocyte Business Overview Table 50. Anemocyte GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Anemocyte GMP Plasmid Service Product Portfolio Table 52. Anemocyte Recent Development Table 53. Catalent Biologics Company Information Table 54. Catalent Biologics Business Overview Table 55. Catalent Biologics GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Catalent Biologics GMP Plasmid Service Product Portfolio Table 57. Catalent Biologics Recent Development Table 58. Creative Biolabs Company Information Table 59. Creative Biolabs Business Overview Table 60. Creative Biolabs GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Creative Biolabs GMP Plasmid Service Product Portfolio Table 62. Creative Biolabs Recent Development Table 63. Esco Aster Company Information Table 64. Esco Aster Business Overview Table 65. Esco Aster GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Esco Aster GMP Plasmid Service Product Portfolio Table 67. Esco Aster Recent Development Table 68. VectorBuilder Company Information Table 69. VectorBuilder Business Overview Table 70. VectorBuilder GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. VectorBuilder GMP Plasmid Service Product Portfolio Table 72. VectorBuilder Recent Development Table 73. Eurogentec Company Information Table 74. Eurogentec Business Overview Table 75. Eurogentec GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Eurogentec GMP Plasmid Service Product Portfolio Table 77. Eurogentec Recent Development Table 78. Pharmaron Company Information Table 79. Pharmaron Business Overview Table 80. Pharmaron GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Pharmaron GMP Plasmid Service Product Portfolio Table 82. Pharmaron Recent Development Table 83. PlasmidFactory GmbH Company Information Table 84. PlasmidFactory GmbH Business Overview Table 85. PlasmidFactory GmbH GMP Plasmid Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. PlasmidFactory GmbH GMP Plasmid Service Product Portfolio Table 87. PlasmidFactory GmbH Recent Development Table 88. ProBio CDMO Company Information Table 89. ProBio CDMO Business Overview Table 90. ProBio CDMO GMP Plasmid Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. ProBio CDMO GMP Plasmid Service Product Portfolio Table 92. ProBio CDMO Recent Development Table 93. Sartorius Company Information Table 94. Sartorius Business Overview Table 95. Sartorius GMP Plasmid Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sartorius GMP Plasmid Service Product Portfolio Table 97. Sartorius Recent Development Table 98. Takara Bio Company Information Table 99. Takara Bio Business Overview Table 100. Takara Bio GMP Plasmid Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Takara Bio GMP Plasmid Service Product Portfolio Table 102. Takara Bio Recent Development Table 103. North America GMP Plasmid Service Revenue by Type (2021-2026) & (US$ Million) Table 104. North America GMP Plasmid Service Revenue by Type (2027-2032) & (US$ Million) Table 105. North America GMP Plasmid Service Revenue by Application (2021-2026) & (US$ Million) Table 106. North America GMP Plasmid Service Revenue by Application (2027-2032) & (US$ Million) Table 107. North America GMP Plasmid Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America GMP Plasmid Service Revenue by Country (2021-2026) & (US$ Million) Table 109. North America GMP Plasmid Service Revenue by Country (US$ Million) & (2027-2032) Table 110. Europe GMP Plasmid Service Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe GMP Plasmid Service Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe GMP Plasmid Service Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe GMP Plasmid Service Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe GMP Plasmid Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe GMP Plasmid Service Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe GMP Plasmid Service Revenue by Country (US$ Million) & (2027-2032) Table 117. China GMP Plasmid Service Revenue by Type (2021-2026) & (US$ Million) Table 118. China GMP Plasmid Service Revenue by Type (2027-2032) & (US$ Million) Table 119. China GMP Plasmid Service Revenue by Application (2021-2026) & (US$ Million) Table 120. China GMP Plasmid Service Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia GMP Plasmid Service Revenue by Type (2021-2026) & (US$ Million) Table 122. Asia GMP Plasmid Service Revenue by Type (2027-2032) & (US$ Million) Table 123. Asia GMP Plasmid Service Revenue by Application (2021-2026) & (US$ Million) Table 124. Asia GMP Plasmid Service Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia GMP Plasmid Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Asia GMP Plasmid Service Revenue by Region (US$ Million) & (2021-2026) Table 127. Asia GMP Plasmid Service Revenue by Region (US$ Million) & (2027-2032) Table 128. SAMEA GMP Plasmid Service Revenue by Type (2021-2026) & (US$ Million) Table 129. SAMEA GMP Plasmid Service Revenue by Type (2027-2032) & (US$ Million) Table 130. SAMEA GMP Plasmid Service Revenue by Application (2021-2026) & (US$ Million) Table 131. SAMEA GMP Plasmid Service Revenue by Application (2027-2032) & (US$ Million) Table 132. SAMEA GMP Plasmid Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. SAMEA GMP Plasmid Service Revenue by Country (2021-2026) & (US$ Million) Table 134. SAMEA GMP Plasmid Service Revenue by Country (US$ Million) & (2027-2032) Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. GMP Plasmid Service Image Figure 2. Global GMP Plasmid Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GMP Plasmid Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plasmid for Viral Vector Production Image Figure 5. Plasmid for Direct-Acting Therapeutics Image Figure 6. Plasmid for In Vitro Transcription Template Image Figure 7. Others Image Figure 8. Global GMP Plasmid Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global GMP Plasmid Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Gene Therapy and Cell Therapy Industry Image Figure 11. mRNA Vaccine and Therapy Industry Image Figure 12. Diagnostic and Scientific Research Reagent Industry Image Figure 13. Others Image Figure 14. Global GMP Plasmid Service Market Size (US$ Million) & (2021-2032) Figure 15. Global GMP Plasmid Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global GMP Plasmid Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global GMP Plasmid Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global GMP Plasmid Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global GMP Plasmid Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global GMP Plasmid Service Revenue Market Share by Type (2021-2032) Figure 22. Global GMP Plasmid Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global GMP Plasmid Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global GMP Plasmid Service Revenue Market Share by Application (2021-2032) Figure 25. North America GMP Plasmid Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America GMP Plasmid Service Revenue Share by Type (2021-2032) Figure 27. North America GMP Plasmid Service Revenue Share by Application (2021-2032) Figure 28. North America GMP Plasmid Service Revenue Share by Country (2021-2032) Figure 29. United States GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe GMP Plasmid Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe GMP Plasmid Service Revenue Share by Type (2021-2032) Figure 34. Europe GMP Plasmid Service Revenue Share by Application (2021-2032) Figure 35. Europe GMP Plasmid Service Revenue Share by Country (2021-2032) Figure 36. Germany GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China GMP Plasmid Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China GMP Plasmid Service Revenue Share by Type (2021-2032) Figure 46. China GMP Plasmid Service Revenue Share by Application (2021-2032) Figure 47. Asia GMP Plasmid Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia GMP Plasmid Service Revenue Share by Type (2021-2032) Figure 49. Asia GMP Plasmid Service Revenue Share by Application (2021-2032) Figure 50. Asia GMP Plasmid Service Revenue Share by Region (2021-2032) Figure 51. Japan GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA GMP Plasmid Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA GMP Plasmid Service Revenue Share by Type (2021-2032) Figure 59. SAMEA GMP Plasmid Service Revenue Share by Application (2021-2032) Figure 60. SAMEA GMP Plasmid Service Revenue Share by Country (2021-2032) Figure 61. Brazil GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt GMP Plasmid Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmid for Viral Vector Production
  • Plasmid for Direct-Acting Therapeutics
  • Plasmid for In Vitro Transcription Template
  • Others
Applications
  • Gene Therapy and Cell Therapy Industry
  • mRNA Vaccine and Therapy Industry
  • Diagnostic and Scientific Research Reagent Industry
  • Others
Companies covered
  • Aldevron
  • Andelyn Biosciences
  • Anemocyte
  • Catalent Biologics
  • Creative Biolabs
  • Esco Aster
  • VectorBuilder
  • Eurogentec
  • Pharmaron
  • PlasmidFactory GmbH
  • ProBio CDMO
  • Sartorius
  • Takara Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GMP Plasmid Service Market by Type
  3. 1.2.1 Global GMP Plasmid Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plasmid for Viral Vector Production
  5. 1.2.3 Plasmid for Direct-Acting Therapeutics
  6. 1.2.4 Plasmid for In Vitro Transcription Template
  7. 1.2.5 Others
  8. 1.3 GMP Plasmid Service Market by Application
  9. 1.3.1 Global GMP Plasmid Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Gene Therapy and Cell Therapy Industry
  11. 1.3.3 mRNA Vaccine and Therapy Industry
  12. 1.3.4 Diagnostic and Scientific Research Reagent Industry
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 GMP Plasmid Service Market Dynamics
  1. 2.1 GMP Plasmid Service Industry Trends
  2. 2.2 GMP Plasmid Service Industry Drivers
  3. 2.3 GMP Plasmid Service Industry Opportunities and Challenges
  4. 2.4 GMP Plasmid Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global GMP Plasmid Service Market Perspective (2021-2032)
  2. 3.2 Global GMP Plasmid Service Growth Trends by Region
  3. 3.2.1 Global GMP Plasmid Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GMP Plasmid Service Market Size by Region (2021-2026)
  5. 3.2.3 Global GMP Plasmid Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global GMP Plasmid Service Revenue by Players
  2. 4.1.1 Global GMP Plasmid Service Revenue by Players (2021-2026)
  3. 4.1.2 Global GMP Plasmid Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global GMP Plasmid Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GMP Plasmid Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global GMP Plasmid Service Key Players Headquarters & Area Served
  7. 4.4 Global GMP Plasmid Service Players, Product Type & Application
  8. 4.5 Global GMP Plasmid Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global GMP Plasmid Service Market CR5 and HHI
  11. 4.6.3 2025 GMP Plasmid Service Tier 1, Tier 2, and Tier 3
5 GMP Plasmid Service Market Size by Type
  1. 5.1 Global GMP Plasmid Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global GMP Plasmid Service Revenue by Type (2021-2032)
  3. 5.3 Global GMP Plasmid Service Revenue Market Share by Type (2021-2032)
6 GMP Plasmid Service Market Size by Application
  1. 6.1 Global GMP Plasmid Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global GMP Plasmid Service Revenue by Application (2021-2032)
  3. 6.3 Global GMP Plasmid Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aldevron
  2. 7.1.1 Aldevron Company Information
  3. 7.1.2 Aldevron Business Overview
  4. 7.1.3 Aldevron GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aldevron GMP Plasmid Service Product Portfolio
  6. 7.1.5 Aldevron Recent Developments
  7. 7.2 Andelyn Biosciences
  8. 7.2.1 Andelyn Biosciences Company Information
  9. 7.2.2 Andelyn Biosciences Business Overview
  10. 7.2.3 Andelyn Biosciences GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Andelyn Biosciences GMP Plasmid Service Product Portfolio
  12. 7.2.5 Andelyn Biosciences Recent Developments
  13. 7.3 Anemocyte
  14. 7.3.1 Anemocyte Company Information
  15. 7.3.2 Anemocyte Business Overview
  16. 7.3.3 Anemocyte GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Anemocyte GMP Plasmid Service Product Portfolio
  18. 7.3.5 Anemocyte Recent Developments
  19. 7.4 Catalent Biologics
  20. 7.4.1 Catalent Biologics Company Information
  21. 7.4.2 Catalent Biologics Business Overview
  22. 7.4.3 Catalent Biologics GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Catalent Biologics GMP Plasmid Service Product Portfolio
  24. 7.4.5 Catalent Biologics Recent Developments
  25. 7.5 Creative Biolabs
  26. 7.5.1 Creative Biolabs Company Information
  27. 7.5.2 Creative Biolabs Business Overview
  28. 7.5.3 Creative Biolabs GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biolabs GMP Plasmid Service Product Portfolio
  30. 7.5.5 Creative Biolabs Recent Developments
  31. 7.6 Esco Aster
  32. 7.6.1 Esco Aster Company Information
  33. 7.6.2 Esco Aster Business Overview
  34. 7.6.3 Esco Aster GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Esco Aster GMP Plasmid Service Product Portfolio
  36. 7.6.5 Esco Aster Recent Developments
  37. 7.7 VectorBuilder
  38. 7.7.1 VectorBuilder Company Information
  39. 7.7.2 VectorBuilder Business Overview
  40. 7.7.3 VectorBuilder GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 VectorBuilder GMP Plasmid Service Product Portfolio
  42. 7.7.5 VectorBuilder Recent Developments
  43. 7.8 Eurogentec
  44. 7.8.1 Eurogentec Company Information
  45. 7.8.2 Eurogentec Business Overview
  46. 7.8.3 Eurogentec GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eurogentec GMP Plasmid Service Product Portfolio
  48. 7.8.5 Eurogentec Recent Developments
  49. 7.9 Pharmaron
  50. 7.9.1 Pharmaron Company Information
  51. 7.9.2 Pharmaron Business Overview
  52. 7.9.3 Pharmaron GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pharmaron GMP Plasmid Service Product Portfolio
  54. 7.9.5 Pharmaron Recent Developments
  55. 7.10 PlasmidFactory GmbH
  56. 7.10.1 PlasmidFactory GmbH Company Information
  57. 7.10.2 PlasmidFactory GmbH Business Overview
  58. 7.10.3 PlasmidFactory GmbH GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 PlasmidFactory GmbH GMP Plasmid Service Product Portfolio
  60. 7.10.5 PlasmidFactory GmbH Recent Developments
  61. 7.11 ProBio CDMO
  62. 7.11.1 ProBio CDMO Company Information
  63. 7.11.2 ProBio CDMO Business Overview
  64. 7.11.3 ProBio CDMO GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ProBio CDMO GMP Plasmid Service Product Portfolio
  66. 7.11.5 ProBio CDMO Recent Developments
  67. 7.12 Sartorius
  68. 7.12.1 Sartorius Company Information
  69. 7.12.2 Sartorius Business Overview
  70. 7.12.3 Sartorius GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sartorius GMP Plasmid Service Product Portfolio
  72. 7.12.5 Sartorius Recent Developments
  73. 7.13 Takara Bio
  74. 7.13.1 Takara Bio Company Information
  75. 7.13.2 Takara Bio Business Overview
  76. 7.13.3 Takara Bio GMP Plasmid Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Takara Bio GMP Plasmid Service Product Portfolio
  78. 7.13.5 Takara Bio Recent Developments
8 North America
  1. 8.1 North America GMP Plasmid Service Revenue (2021-2032)
  2. 8.2 North America GMP Plasmid Service Revenue by Type (2021-2032)
  3. 8.2.1 North America GMP Plasmid Service Revenue by Type (2021-2026)
  4. 8.2.2 North America GMP Plasmid Service Revenue by Type (2027-2032)
  5. 8.3 North America GMP Plasmid Service Revenue Share by Type (2021-2032)
  6. 8.4 North America GMP Plasmid Service Revenue by Application (2021-2032)
  7. 8.4.1 North America GMP Plasmid Service Revenue by Application (2021-2026)
  8. 8.4.2 North America GMP Plasmid Service Revenue by Application (2027-2032)
  9. 8.5 North America GMP Plasmid Service Revenue Share by Application (2021-2032)
  10. 8.6 North America GMP Plasmid Service Revenue by Country
  11. 8.6.1 North America GMP Plasmid Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America GMP Plasmid Service Revenue by Country (2021-2026)
  13. 8.6.3 North America GMP Plasmid Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe GMP Plasmid Service Revenue (2021-2032)
  2. 9.2 Europe GMP Plasmid Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe GMP Plasmid Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe GMP Plasmid Service Revenue by Type (2027-2032)
  5. 9.3 Europe GMP Plasmid Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe GMP Plasmid Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe GMP Plasmid Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe GMP Plasmid Service Revenue by Application (2027-2032)
  9. 9.5 Europe GMP Plasmid Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe GMP Plasmid Service Revenue by Country
  11. 9.6.1 Europe GMP Plasmid Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe GMP Plasmid Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe GMP Plasmid Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China GMP Plasmid Service Revenue (2021-2032)
  2. 10.2 China GMP Plasmid Service Revenue by Type (2021-2032)
  3. 10.2.1 China GMP Plasmid Service Revenue by Type (2021-2026)
  4. 10.2.2 China GMP Plasmid Service Revenue by Type (2027-2032)
  5. 10.3 China GMP Plasmid Service Revenue Share by Type (2021-2032)
  6. 10.4 China GMP Plasmid Service Revenue by Application (2021-2032)
  7. 10.4.1 China GMP Plasmid Service Revenue by Application (2021-2026)
  8. 10.4.2 China GMP Plasmid Service Revenue by Application (2027-2032)
  9. 10.5 China GMP Plasmid Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GMP Plasmid Service Revenue (2021-2032)
  2. 11.2 Asia GMP Plasmid Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia GMP Plasmid Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia GMP Plasmid Service Revenue by Type (2027-2032)
  5. 11.3 Asia GMP Plasmid Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia GMP Plasmid Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia GMP Plasmid Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia GMP Plasmid Service Revenue by Application (2027-2032)
  9. 11.5 Asia GMP Plasmid Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia GMP Plasmid Service Revenue by Country
  11. 11.6.1 Asia GMP Plasmid Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia GMP Plasmid Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia GMP Plasmid Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GMP Plasmid Service Revenue (2021-2032)
  2. 12.2 SAMEA GMP Plasmid Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA GMP Plasmid Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA GMP Plasmid Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA GMP Plasmid Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA GMP Plasmid Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA GMP Plasmid Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA GMP Plasmid Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA GMP Plasmid Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA GMP Plasmid Service Revenue by Country
  11. 12.6.1 SAMEA GMP Plasmid Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA GMP Plasmid Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA GMP Plasmid Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst